1. Home
  2. TPVG vs PRQR Comparison

TPVG vs PRQR Comparison

Compare TPVG & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TPVG
  • PRQR
  • Stock Information
  • Founded
  • TPVG 2013
  • PRQR 2012
  • Country
  • TPVG United States
  • PRQR Netherlands
  • Employees
  • TPVG N/A
  • PRQR N/A
  • Industry
  • TPVG Other Consumer Services
  • PRQR Biotechnology: Pharmaceutical Preparations
  • Sector
  • TPVG Consumer Discretionary
  • PRQR Health Care
  • Exchange
  • TPVG Nasdaq
  • PRQR Nasdaq
  • Market Cap
  • TPVG 316.4M
  • PRQR 309.5M
  • IPO Year
  • TPVG N/A
  • PRQR 2014
  • Fundamental
  • Price
  • TPVG $8.04
  • PRQR $3.63
  • Analyst Decision
  • TPVG Hold
  • PRQR Strong Buy
  • Analyst Count
  • TPVG 6
  • PRQR 4
  • Target Price
  • TPVG $7.81
  • PRQR $7.13
  • AVG Volume (30 Days)
  • TPVG 314.2K
  • PRQR 663.4K
  • Earning Date
  • TPVG 11-06-2024
  • PRQR 11-07-2024
  • Dividend Yield
  • TPVG 18.90%
  • PRQR N/A
  • EPS Growth
  • TPVG N/A
  • PRQR N/A
  • EPS
  • TPVG 0.27
  • PRQR N/A
  • Revenue
  • TPVG $115,271,000.00
  • PRQR $20,506,357.00
  • Revenue This Year
  • TPVG N/A
  • PRQR $298.83
  • Revenue Next Year
  • TPVG N/A
  • PRQR N/A
  • P/E Ratio
  • TPVG $29.14
  • PRQR N/A
  • Revenue Growth
  • TPVG N/A
  • PRQR 306.68
  • 52 Week Low
  • TPVG $6.44
  • PRQR $1.18
  • 52 Week High
  • TPVG $11.58
  • PRQR $4.62
  • Technical
  • Relative Strength Index (RSI)
  • TPVG 71.35
  • PRQR 56.97
  • Support Level
  • TPVG $7.83
  • PRQR $3.57
  • Resistance Level
  • TPVG $8.02
  • PRQR $4.21
  • Average True Range (ATR)
  • TPVG 0.20
  • PRQR 0.24
  • MACD
  • TPVG 0.07
  • PRQR -0.07
  • Stochastic Oscillator
  • TPVG 95.57
  • PRQR 31.47

About TPVG TriplePoint Venture Growth BDC Corp.

TriplePoint Venture Growth BDC Corp is a closed-end, non-diversified management investment company. Its investment objective is to maximize its total return to stockholders in the form of current income and, to a lesser extent, capital appreciation. The fund focuses on companies operating in the fields of biofuels, business applications software, wireless communications equipment, e-commerce, clothing and accessories, conferencing equipment and services, personal goods, financial institutions and services, entertainment, mixed retailing, and healthcare services. Geographically, all the operations of the firm function through the region of the United states.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.

Share on Social Networks: